Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Acorda Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 36 | 34 | −2 |
| Shares | 3.20M | 3.97M | +763.5K (+23.8%) |
| Value | $14.7M | $9.48M | −$5.26M (−35.7%) |
New holders (5)
Institutions that held Acorda Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 282,193 | $674.0K | 0.02% |
| Citadel Advisors LLC | 14,455 | $35.0K | 0.00% |
| HN Saltoro Capital, LP | 14,848 | $35.0K | 0.03% |
| Simplex Trading, LLC | 9,393 | $22.0K | 0.00% |
| Private Capital Group, LLC | 10 | $0 | 0.00% |
Sold out (7)
Institutions that held Acorda Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| AE Wealth Management LLC | 40,457 | $186.0K |
| Susquehanna International Group, LLP | 35,850 | $165.0K |
| Apollon Wealth Management, LLC | 15,000 | $69.0K |
| Two Sigma Investments, LP | 10,855 | $50.0K |
| O'Shaughnessy Asset Management, LLC | 1 | $0 |
| Tower Research Capital LLC (TRC) | 6 | $0 |
| Cutler Group LP | 117 | $0 |